•
Dec 31, 2022

iTeos Therapeutics Q4 2022 Earnings Report

Total Revenue
$53.9K
Previous year: $241M
-100.0%
EPS
$0.54
Previous year: $4.88
-88.9%
Gross Profit
$53.7M
Previous year: $240M
-77.7%
Cash and Equivalents
$285M
Previous year: $849M
-66.4%
Free Cash Flow
-$27.3M
Previous year: -$59M
-53.7%
Total Assets
$755M
Previous year: $885M
-14.7%

iTeos Therapeutics

iTeos Therapeutics